A novel treatment for ischemic stroke: preclinical assessment in the nonhuman primate [ 2015 - ]

Research Grant

Researchers: A/Pr James Bourne (Principal investigator) ,  Prof Stephen Strittmatter

Brief description A major source of repair inhibition after brain injury is debris from dying cells, which contains proteins that hinder repair. This project will examine the expression of these proteins in a clinically-relevant model of ischemic stroke and determine if blocking the effect of these proteins neutralises their repair-inhibiting properties. If successful, there is likelihood that this drug, and method of delivery, could be translated into the human for treatment following an ischemic stroke.

Funding Amount $739,154.00

Funding Scheme Project Grants

Notes Standard Project Grant